Coeptis Therapeutics, Inc. Operating Lease Right-of-Use Assets
Coeptis Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $68.54 thousand as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2022-11-08
- 2022-09-30: Operating Lease, Right-of-Use Asset $68.54K.
- 2022-06-30: Operating Lease, Right-of-Use Asset $77.95K.
- 2022-03-31: Operating Lease, Right-of-Use Asset $87.14K.
- 2021-12-31: Operating Lease, Right-of-Use Asset $17.93K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2022-09-30 | $68.54K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $77.95K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $87.14K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $17.93K 10-Q · filed 2022-11-08 |
| 2021-09-30 | $28.35K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $38.54K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $48.50K 10-Q/A · filed 2021-05-18 |
| 2020-12-31 | $58.23K 10-K · filed 2022-03-11 |